Brickell Biotech Stock Target Price and Analyst Consensus

BBI
 Stock
  

USD 0.12  0.00  0.00%   

The current analyst and expert consensus on Brickell Biotech is Strong Buy, with 0 strong sell and 1 strong buy opinions. The current projected Brickell Biotech target price consensus is 4.0 with 1 analyst opinions. The most common way Brickell Biotech analysts use to provide recommendation to the public is financial statements analysis. Many experts also interview Brickell Biotech executives and customers to further validate their buy or sell advice. Please note, the number of analysts providing the opinion is not sufficient to provide adequate consensus on Brickell Biotech. We encourage you to use your own analysis of Brickell Biotech to validate this buy or sell advice. Brickell Biotech buy-or-sell recommendation module provides average expert sentiment on the projected Brickell Biotech target price to derive its highest and lowest estimates based on projected price volatility of 0.0. Continue to Macroaxis Advice on Brickell Biotech to cross-verify analyst projections. Unlike analyst recommendations, Macroaxis provides advice only from the perspective of investor risk tolerance and investment horizon.
  
Refresh
The current Gross Profit is estimated to increase to about 414.6 K, while Profit Margin is projected to decrease to (100.28) . Brickell Biotech Current Assets are most likely to decrease significantly in the upcoming years. The last year's value of Current Assets was reported at 29.6 Million. The current Assets Non Current is estimated to increase to about 120.1 K, while Accumulated Other Comprehensive Income is projected to decrease to (25.9 K).

Brickell Biotech Target Price Consensus

We track the performance of the top 100 financial experts across various large and mid-size financial boutiques. Brickell target price is determined by taking all analyst projections and averaging them out. There is no one specific way to measure analysis performance other than comparing it to the past results via a very sophisticated attribution analysis. Brickell target price projections below should be used in combination with other traditional price prediction techniques such as stock price forecasting, technical analysis, earnings estimate, and various momentum models.
Number of OpinionsOne
Lowered Outlook0
Raized Outlook0
Strong Buy
Most Brickell analysts issue ratings four times a year, at intervals of three months. Ratings are usually accompanied by a target price to helps potential investors understand Brickell stock's fair price compared to its market value. Analysts arrive at stock ratings after researching public financial statements of Brickell Biotech, talking to its executives and customers, or listening to those companies' conference calls.
Macroaxis Advice   Exposure   Valuation

Brickell Biotech Target Price Projection

Brickell Biotech's current and average target prices are 0.12 and 4.00, respectively. The current price of Brickell Biotech is the price at which Brickell Biotech is currently trading. On the other hand, Brickell Biotech's target price is what analysts think the stock is worth or could sell for in the future. The more significant the discrepancy between the two prices, the more it stimulates investors to act.

Current Price

Brickell Biotech Market Quote on 27th of June 2022

Low Price0.12Odds
High Price0.12Odds

0.12

Target Price

Analyst Consensus On Brickell Biotech Target Price

Low Estimate4.0Odds
High Estimate4.0Odds
Number of AnalystsOne
Standard Deviation0.0

4.0

Note that most analysts generally publish their price targets in research reports on specific companies, along with recommendations for the company's stock.Although price targets are often quoted in the financial news media, there could be a delay between the publication of the latest analyst outlook on Brickell Biotech and the information provided on this page.

Brickell Biotech Analyst Ratings

Brickell Biotech's analyst stock recommendations are determined by taking an average estimate of all analysts we track and classifying them as Strong Buy, Buy, Hold, Strong Sell, or Sell. Ratings generally communicate what analysts sense about Brickell Biotech stock, and they use a lot of effort and time to analyze it and arrive at a rating. That suggests that analyst recommendations are the outcome of an objective and thorough examination of Brickell Biotech's financials, market performance, and future outlook by experienced professionals. Brickell Biotech's historical ratings below, therefore, can serve as a valuable tool for investors.

Analyst Consensus Breakdown

Average Consensus Estimates

About Brickell Biotech Target Price Projections

Brickell Biotech's target price is an analyst's projection of its future price. Price targets can be assigned to all types of securities, from complex investment products to stocks such as Brickell Biotech and even bonds. If the target price is unavailable, it is most likely because there were not enough analyst opinions to come up with a consensus estimate. When setting a price target estimate, an analyst is trying to determine what the Stock is worth and where the price will be in a year from now. Generally, the target price of Brickell depends on its intrinsic valuation, beta (i.e., risk over market), and overall volatility. Most analysts publish their price targets in research reports on specific companies, along with their buy, hold, or sell recommendations. Stock price targets are often quoted in the financial news media. Macroaxis uses multiple feeds to provide overall target price projection for Brickell Biotech including its fundamental analysis.
 2017 2018 2021 2022 (projected)
Accounts Payable Turnover17.962.02.32.36
PPandE Turnover15.544.594.144.69

Additional Brickell Biotech Value Projection Modules

Most investment researchers agree that the mispricing and readjustment of any Stock value happens often and is sometimes even predictable, but there is no strong theory explaining why it happens. The current price of Brickell Biotech is a key component of Brickell Biotech valuation and have some predictive power on the future returns of a Brickell Biotech.
Sophisticated investors, who have witnessed many market ups and downs, frequently view the market will even out over time. This tendency of Brickell Biotech's price to converge to an average value over time is called mean reversion. However, historically, high market prices usually discourage investors that believe in mean reversion to invest, while low prices are viewed as an opportunity to buy. Please use the tools below to analyze the current value of Brickell Biotech in the context of predictive analytics.
Hype
Prediction
LowEstimated ValueHigh
0.010.127.44
Details
Intrinsic
Valuation
LowReal ValueHigh
0.051.098.41
Details
Naive
Forecast
LowNext ValueHigh
0.0017010.097.41
Details
Earnings
Estimates (1)
LowProjected EPSHigh
-0.53-0.53-0.53
Details
Please note, it is not enough to conduct a financial or market analysis of a single entity such as Brickell Biotech. Your research has to be compared to or analyzed against Brickell Biotech's peers to derive any actionable benefits. When done correctly, Brickell Biotech's competitive analysis will give you plenty of quantitative and qualitative data to validate your investment decisions or develop an entirely new strategy towards taking a position in Brickell Biotech.

Trending Themes

If you are a self-driven investor, you will appreciate our idea-generating investing themes. Our themes help you align your investments inspirations with your core values and are essential building blocks of your portfolios. A typical investing theme is an unweighted collection of up to 20 funds, stocks, ETFs, or cryptocurrencies that are programmatically selected from a pull of equities with common characteristics such as industry and growth potential, volatility, or market segment.
Top FinTech
Invested over 90 shares
Food Products
Invested over 90 shares
Impulse
Invested over 90 shares
Military Industrial
Invested over 90 shares
Giant Impact
Invested over 90 shares
Continue to Macroaxis Advice on Brickell Biotech to cross-verify analyst projections. Unlike analyst recommendations, Macroaxis provides advice only from the perspective of investor risk tolerance and investment horizon. Note that the Brickell Biotech information on this page should be used as a complementary analysis to other Brickell Biotech's statistical models used to find the right mix of equity instruments to add to your existing portfolios or create a brand new portfolio. You can also try Price Ceiling Movement module to calculate and plot Price Ceiling Movement for different equity instruments.

Complementary Tools for Brickell Stock analysis

When running Brickell Biotech price analysis, check to measure Brickell Biotech's market volatility, profitability, liquidity, solvency, efficiency, growth potential, financial leverage, and other vital indicators. We have many different tools that can be utilized to determine how healthy Brickell Biotech is operating at the current time. Most of Brickell Biotech's value examination focuses on studying past and present price action to predict the probability of Brickell Biotech's future price movements. You can analyze the entity against its peers and financial market as a whole to determine factors that move Brickell Biotech's price. Additionally, you may evaluate how the addition of Brickell Biotech to your portfolios can decrease your overall portfolio volatility.
Watchlist Optimization
Optimize watchlists to build efficient portfolio or rebalance existing positions based on mean-variance optimization algorithm
Go
Correlation Analysis
Reduce portfolio risk simply by holding instruments which are not perfectly correlated
Go
Sync Your Broker
Sync your existing holdings, watchlists, positions or portfolios from thousands of online brokerage services, banks, investment account aggregators and robo-advisors.
Go
Equity Search
Search for actively traded equities including funds and ETFs from over 30 global markets
Go
Portfolio Volatility
Check portfolio volatility and analyze historical return density to properly model market risk
Go
Idea Analyzer
Analyze all characteristics, volatility and risk-adjusted return of Macroaxis ideas
Go
Money Flow Index
Determine momentum by analyzing Money Flow Index and other technical indicators
Go
Fundamentals Comparison
Compare fundamentals across multiple equities to find investing opportunities
Go
Price Exposure Probability
Analyze equity upside and downside potential for a given time horizon across multiple markets
Go
Premium Stories
Follow Macroaxis premium stories from verified contributors across different equity types, categories and coverage scope
Go
Piotroski F Score
Get Piotroski F Score based on binary analysis strategy of nine different fundamentals
Go
The data published in Brickell Biotech's official financial statements usually reflect Brickell Biotech's business processes, product offerings, services, and other fundamental events. But there are other numbers, ratios, or fundamental indicators derived from these statements that are easier to understand and visualize within the underlying realities that drive quantitative information of Brickell Biotech. For example, before you start analyzing numbers published by Brickell accountants, it's critical to develop an understanding of what Brickell Biotech's liquidity, profitability, and earnings quality are in the context of the Pharmaceutical Products space in which it operates.
Please note, the presentation of Brickell Biotech's financial position, as portrayed in its financial statements, is often influenced by management's estimates, judgments, and sometimes even manipulations. In the best case, Brickell Biotech's management is honest, while the outside auditors are strict and uncompromising. Whatever the case, the imprecision that can be found in Brickell Biotech's accounting process means that the reasonable investor should take a skeptical approach toward the financial statement analysis of Brickell Biotech. Please utilize our Beneish M Score to check the likelihood of Brickell Biotech's management to manipulate its earnings.